In Brief: FDA Office of Public Affairs
This article was originally published in The Gray Sheet
Executive Summary
FDA Office of Public Affairs: Deputy Commissioner for Policy Donald McLearn will leave the agency for a position at the Washington, D.C. public relations firm Fleishman-Hillard. A replacement likely will be named after appointment of the new FDA Commissioner. McLearn has been at FDA since 1980, serving in various capacities such as deputy director of the publications staff in both the Office of Legislation and Information and the Office of Public Affairs...